Join Merck, OncoMed, MedImmune, Boston Healthcare, Kimmel Cancer Center, and Other Thought Leaders at The International Symposium for Tissue Phenomics™

Alongside genomics, Tissue Phenomics™ is a key driver in the growth of personalized medicine and the improvement of patient lives. The unique ability of Tissue Phenomics’ to extract detailed quantitative data from tissue images and correlate that data with genomic signatures and patient demographics uniquely positions Tissue Phenomics™ to impact how novel cancer treatments and diagnostics are discovered, validated and commercialized.

Join us at The International Symposium for Tissue Phenomics™ to take part in the conversation with thought leaders from around the globe on companion diagnostics, immunotherapy, and tissue-based patient stratification for personalized medicine. Presentations will include pragmatic approaches to development of companion diagnostics, analysis of data, and validation of assays used to drive therapies.

Speakers will include industry leaders from cutting edge organizations such as Merck, OncoMed Pharmaceuticals, MedImmune, Frederick National Laboratory for Cancer Research, Kimmel Cancer Center, and University Medical Center Heidelberg.

Dates: October 17-18, 2014

Location: Hilton San Francisco Financial District, San Francisco, California

Come learn from Tissue Phenomics™ experts and key opinion leaders in oncology on how:

• Tissue images can be turned into big data for robust correlation to clinical outcomes
• Immuno-oncology is accelerating using quantitative spatial analysis of the tumor microenvironment
• Thought leaders are using Tissue Phenomics™ to find new markers for stratifying populations

View the program agenda to register and to learn about our special group discounts.